Artes Biotechnology GmbH, Select Vaccines deal

Artes acquired Anavax virus-like particle (VLP) technology from Select Vaccines for an undisclosed upfront payment. Anavax also is eligible for double-digit royalties. Select Vaccines plans to combine...